SUNITINIB MALATE AS MAINTENANCE THERAPY IN PATIENTS (PTS) WITH LOCALLY ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER (NSCLC): A PHASE II STUDY

被引：0
|
作者：
Blais, N. [1 ]
Page, R. [2 ]
Hainsworth, J. [3 ]
Soria, J. [4 ]
Laskin, J. [5 ]
Hamm, J. T. [6 ]
Selaru, P. [7 ]
Kim, S. T. [7 ]
Chao, R. [7 ]
Gervais, R. [8 ]
机构：
[1] CHUM Hop Notre Dame, Montreal, PQ, Canada
[2] Ctr Canc & Blood Disorders, Ft Worth, TX USA
[3] Sarah Cannon Res Inst, Nashville, TN USA
[4] Inst Gustave Roussy, Villejuif, France
[5] BC Canc Agcy, Vancouver, BC, Canada
[6] Norton Canc Inst, Louisville, KY USA
[7] Pfizer Inc, Global Res & Dev, La Jolla, CA USA
[8] Oncol Inst F Baclesse Ctr, Caen, France
来源：
ANNALS OF ONCOLOGY | 2008年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：109 / 109
页数：1
相关论文
共 50 条
  • [21] Phase II study of cetuximab in combination with carboplatin and docetaxel for patients with advanced/metastatic non-small cell lung cancer (NSCLC)
    Belani, C. P.
    Ramalingam, S.
    Schreeder, M.
    Steis, R.
    Guidice, R.
    Marshland, T.
    Butler, B.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [22] Gemcitabine in locally advanced and metastatic non-small cell lung cancer: The Central European phase II study
    Zatloukal, P
    Kanitz, E
    Magyar, P
    Jassem, J
    Krzakowski, M
    Pawlicki, M
    Petruzelka, L
    Chovan, L
    Pesek, M
    Janko, C
    Krejcy, K
    LUNG CANCER, 1998, 22 (03) : 243 - 250
  • [23] Interim results of a phase II trial of docetaxel in combination with cisplatin in patients with metastatic or locally advanced non-small cell lung cancer (NSCLC)
    Zalcberg, JR
    Bishop, JF
    Millward, MJ
    Zimet, A
    Laird, J
    Barter, C
    Seward, D
    McKeage, MJ
    Friedlander, ML
    Toner, G
    Berille, J
    Blanc, C
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 1084 - 1084
  • [24] Phase II study of nivolumab in patients with advanced non-small cell lung cancer (NSCLC) in Korea
    Cho, E. K.
    Kang, J. H.
    Han, J-Y.
    Lee, J. S.
    Kim, D-W.
    Kim, S-W.
    Min, Y. J.
    Lee, K. H.
    Kim, J-H.
    Park, K.
    ANNALS OF ONCOLOGY, 2017, 28
  • [25] Pemetrexed for the maintenance treatment of locally advanced or metastatic non-small cell lung cancer
    Greenhalgh, J.
    McLeod, C.
    Bagust, A.
    Boland, A.
    Fleeman, N.
    Dundar, Y.
    Oyee, J.
    Dickson, R.
    Davis, H.
    Green, J.
    McKenna, E.
    Pearson, M.
    HEALTH TECHNOLOGY ASSESSMENT, 2010, 14 : 33 - 39
  • [26] A phase II study of continuous daily sunitinib dosing in patients with previously-treated advanced non-small cell lung cancer (NSCLC)
    Scagliotti, Giorgio V.
    Novello, Silvia
    Brahamer, Julie R.
    Govindan, Ramaswamy
    Rosell, Rafael
    Belani, Chandra P.
    Atkins, James N.
    Tye, Lesley
    Chao, Richard
    Socinski, Mark A.
    JOURNAL OF THORACIC ONCOLOGY, 2007, 2 (08) : S470 - S470
  • [27] Phase IV Study of Afatinib in Locally Advanced or Metastatic Non-Small Cell Lung Cancer
    Thongprasert, Sumitra
    Boldeanu, Cosmin
    Radosavljevic, Davorin
    Petrovic, Marina
    Jones, Hilary
    Cseh, Agnieszka
    Gaafar, Rabab
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S667 - S667
  • [28] Approval Summary: Pemetrexed Maintenance Therapy of Advanced/Metastatic Nonsquamous, Non-Small Cell Lung Cancer (NSCLC)
    Cohen, Martin H.
    Cortazar, Patricia
    Justice, Robert
    Pazdur, Richard
    ONCOLOGIST, 2010, 15 (12): : 1352 - 1358
  • [29] SUNITINIB (SU) IN COMBINATION WITH ERLOTINIB (E) FOR THE TREATMENT OF ADVANCED/METASTATIC NON-SMALL CELL LUNG CANCER (NSCLC): A PHASE III STUDY
    Scagliotti, G. V.
    Krzakowski, M.
    Szczesna, A.
    Strausz, J.
    Makhson, A.
    Reck, M.
    Tye, L.
    Selaru, P.
    Chao, R. C.
    Govindan, R.
    ANNALS OF ONCOLOGY, 2010, 21 : 3 - 4
  • [30] Palliative thoracic radiotherapy in locally advanced/metastatic non-small cell lung cancer (NSCLC)
    Maclennan, K.
    Campbell, S.
    Little, F.
    Erridge, S.
    Evans, T.
    Price, A.
    LUNG CANCER, 2016, 91 : S53 - S54
12345